ArticleFrontiers in oncology2022

Real-life analysis of neoadjuvant-therapy-associated benefits for pathological complete response and survival in early breast cancer patients - role of trastuzumab in HER2+ BC and platinum in TNBC.

Wei-Pang Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.